Guideline for the management of knee and hip osteoarthritis

Recommendations

Anti-osteoporosis drugs

Pharmacological interventions

Anti-osteoporosis drugs


 

Intervention: Bisphosphonates – Knee and/or hip

Recommendation

We suggest not offering bisphosphonates for people with knee and/or hip osteoarthritis (OA).

Strength of recommendation

Conditional against recommendation

Quality of evidence

Very low

Intervention: Calcitonin – Knee and/or hip

Recommendation

We suggest not offering calcitonin for people with knee and/or hip OA

Strength of recommendation

Conditional against recommendation

Quality of evidence

Very low

Intervention: Strontium ranelate – Knee and/or hip

Recommendation

We do not recommend offering strontium ranelate for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Moderate

This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log

Advertising